ConductScience.org, home

Paper39376010

Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.

Clarke BL and 19 others. J Clin Endocrinol Metab, 2025. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. Papers, record 39376010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39376010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
2025
PubMed
Publication types
Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
12.56, provisional
iCite
Revised in PubMed
2025-06-22
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clarke BLBart L
2Khan AAAliya A
3Rubin MRMishaela R
4Schwarz PPeter
5Vokes TTamara
6Shoback DMDolores Mhttps://orcid.org/0000-0003-2936-4468
7Gagnon CClaudiahttps://orcid.org/0000-0001-9623-962X
8Palermo AAndreahttps://orcid.org/0000-0002-1143-4926
9Abbott LGLisa G
10Hofbauer LCLorenz C
11Kohlmeier LLynn
12Cetani FFilomenahttps://orcid.org/0000-0003-2558-9547
13Pihl SSusanne
14An XXuebei
15Smith ARAlden R
16Lai BBryant
17Ukena JJenny
18Sibley CTChristopher T
19Shu ADAimee Dhttps://orcid.org/0000-0003-1801-5289
20Rejnmark LLarshttps://orcid.org/0000-0002-2152-4247

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypoparathyroidismMajor topic
Parathyroid HormoneMajor topic
Humans
Female
Male
Middle Aged
Adult
Double-Blind Method
Calcium
Bone Density
Treatment Outcome
Aged
Quality of Life

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Ascendis Pharma Bone Diseases A/S, Hellerup, DenmarkPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in39903658Correction to: "Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial".https://conductscience.org/library/papers/39903658

Source PubMed

Download CSV of comments and corrections

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134347093PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.J Clin Endocrinol Metab2022https://conductscience.org/library/papers/34347093PubMed
234374868Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES).J Patient Rep Outcomes2021https://conductscience.org/library/papers/34374868PubMed
331721256Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey.Clin Endocrinol (Oxf)2020https://conductscience.org/library/papers/31721256PubMed
428822059Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review.Endocrine2017https://conductscience.org/library/papers/28822059PubMed
528857066Hypoparathyroidism.Nat Rev Dis Primers2017https://conductscience.org/library/papers/28857066PubMed
636271471Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.J Bone Miner Res2023https://conductscience.org/library/papers/36271471PubMed
736054621Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.J Bone Miner Res2022https://conductscience.org/library/papers/36054621PubMed
826943719Management of Hypoparathyroidism: Summary Statement and Guidelines.J Clin Endocrinol Metab2016https://conductscience.org/library/papers/26943719PubMed
931291476Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism.J Bone Miner Res2019https://conductscience.org/library/papers/31291476PubMed
1031552607Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom).Patient2020https://conductscience.org/library/papers/31552607PubMed
1134825891Low health-related quality of life in hypoparathyroidism and need for PTH analog.Endocr Connect2022https://conductscience.org/library/papers/34825891PubMed
1226943721Presentation of Hypoparathyroidism: Etiologies and Clinical Features.J Clin Endocrinol Metab2016https://conductscience.org/library/papers/26943721PubMed
1333200346Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism.Rev Endocr Metab Disord2021https://conductscience.org/library/papers/33200346PubMed
1432765831Recent advances in understanding and managing hypoparathyroidism.F1000Res2020https://conductscience.org/library/papers/32765831PubMed
1532212275A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults.J Bone Miner Res2020https://conductscience.org/library/papers/32212275PubMed

Download CSV of references

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42978850Eneboparatide induces prolonged 24-hour PTH 1 receptor activation.Ther Adv Rare Dis2026https://conductscience.org/library/papers/42978850PubMed
42881908Contemporary and Emerging Therapeutic Strategies in Hypoparathyroidism: From Conventional Treatment to Restoration of Parathyroid Function.J Clin Med2026https://conductscience.org/library/papers/42881908PubMed
42768234Immunogenicity Profile of Lonapegsomatropin During Long-Term Treatment in Children With Growth Hormone Deficiency.AAPS J2026https://conductscience.org/library/papers/42768234PubMed
42733369[Resolution of the Joint Meeting of the Expert Council "Hypoparathyroidism in the Era of Complex Problems and Breakthrough Technologies"].Probl Endokrinol (Mosk)2026https://conductscience.org/library/papers/42733369PubMed
42614145Palopegteriparatide treatment for hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case series and literature update.JBMR Plus2026https://conductscience.org/library/papers/42614145PubMed
42560456Italian guidelines for the management of adult individuals with post-surgical hypoparathyroidism.J Endocrinol Invest2026https://conductscience.org/library/papers/42560456PubMed
42440695Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism.J Endocr Soc2026https://conductscience.org/library/papers/42440695PubMed
42435057Clinical Characteristics, Treatment Patterns, and Complications in Permanent Hypoparathyroidism: A Large Retrospective Cross-Sectional Study.Calcif Tissue Int2026https://conductscience.org/library/papers/42435057PubMed
42227095[Complications of Pseudohypoparathyroidism and Congenital Forms of Hypoparathyroidism in Children].Probl Endokrinol (Mosk)2026https://conductscience.org/library/papers/42227095PubMed
42081067Risk factors of renal complications in childhood-onset non-surgical hypoparathyroidism: a long-term follow-up study.Endocrine2026https://conductscience.org/library/papers/42081067PubMed
41961369Management of patients with hypoparathyroidism: a Delphi consensus analysis.J Endocrinol Invest2026https://conductscience.org/library/papers/41961369PubMed
41909156Successful transition from rhPTH(1-84) to palopegteriparatide in chronic hypoparathyroidism.JCEM Case Rep2026https://conductscience.org/library/papers/41909156PubMed
41805032Neural plasticity impairment in chronic post-surgical hypoparathyroidism: a cross-sectional and prospective pilot study.Endocr Connect2026https://conductscience.org/library/papers/41805032PubMed
41780637Discovery and characterization of canvuparatide, a once-weekly parathyroid hormone analog for the treatment of hypoparathyroidism.Mol Metab2026https://conductscience.org/library/papers/41780637PubMed
41365829Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension.J Clin Endocrinol Metab2026https://conductscience.org/library/papers/41365829PubMed
41335198Unveiling the complexities of hypoparathyroidism: a comprehensive review of clinical manifestations, diagnosis, and novel therapies.J Endocrinol Invest2026https://conductscience.org/library/papers/41335198PubMed
41260697Palopegteriparatide in Japanese adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway Japan trial.Endocr J2026https://conductscience.org/library/papers/41260697PubMed
41134515Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA).Adv Ther2025https://conductscience.org/library/papers/41134515PubMed
40956444Rebound Effect Following the Discontinuation of Palopegteriparatide.Calcif Tissue Int2025https://conductscience.org/library/papers/40956444PubMed
40924119The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review.Osteoporos Int2025https://conductscience.org/library/papers/40924119PubMed

See all 26 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PTH5741PubTator's text mininghttps://conductscience.org/library/genes/5741

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39376010

GET https://conductscience.org/api/papers/v1/39376010/cited_by?page=2